A detailed history of Ci Investments Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Ci Investments Inc. holds 10,015 shares of RPRX stock, worth $257,385. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,015
Previous 10,051 0.36%
Holding current value
$257,385
Previous $265,000 6.79%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$25.63 - $29.27 $922 - $1,053
-36 Reduced 0.36%
10,015 $283,000
Q2 2024

Aug 12, 2024

SELL
$26.26 - $29.9 $38,917 - $44,311
-1,482 Reduced 12.85%
10,051 $265,000
Q1 2024

May 13, 2024

BUY
$27.46 - $31.33 $144,549 - $164,921
5,264 Added 83.97%
11,533 $350,000
Q4 2023

Feb 12, 2024

SELL
$26.21 - $29.22 $27,284 - $30,418
-1,041 Reduced 14.24%
6,269 $176,000
Q3 2023

Nov 13, 2023

SELL
$26.26 - $31.38 $25,130 - $30,030
-957 Reduced 11.58%
7,310 $198,000
Q2 2023

Aug 11, 2023

BUY
$29.6 - $36.56 $118,607 - $146,495
4,007 Added 94.06%
8,267 $254,000
Q1 2023

May 12, 2023

BUY
$32.77 - $39.4 $88,151 - $105,986
2,690 Added 171.34%
4,260 $153,000
Q4 2022

Feb 10, 2023

BUY
$39.17 - $44.04 $23,697 - $26,644
605 Added 62.69%
1,570 $62,000
Q3 2022

Nov 14, 2022

BUY
$39.88 - $44.65 $17,028 - $19,065
427 Added 79.37%
965 $39,000
Q2 2022

Aug 12, 2022

SELL
$37.53 - $44.22 $43,084 - $50,764
-1,148 Reduced 68.09%
538 $23,000
Q1 2022

May 12, 2022

SELL
$37.46 - $42.44 $8,316 - $9,421
-222 Reduced 11.64%
1,686 $66,000
Q4 2021

Feb 11, 2022

BUY
$35.17 - $42.48 $18,007 - $21,749
512 Added 36.68%
1,908 $76,000
Q3 2021

Nov 12, 2021

BUY
$36.14 - $42.24 $50,451 - $58,967
1,396 New
1,396 $50,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.2B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Ci Investments Inc. Portfolio

Follow Ci Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.